Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society

BACKGROUND: Neuropathic pain (NeP), redefined as pain caused by a lesion or a disease of the somatosensory system, is a disabling condition that affects approximately two million Canadians. OBJECTIVE: To review the randomized controlled trials (RCTs) and systematic reviews related to the pharmacolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Moulin, DE, Boulanger, A, Clark, AJ, Clarke, H, Dao, T, Finley, GA, Furlan, A, Gilron, I, Gordon, A, Morley-Forster, PK, Sessle, BJ, Squire, P, Stinson, J, Taenzer, P, Velly, A, Ware, MA, Weinberg, EL, Williamson, OD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pulsus Group Inc 2014
Materias:
Consensus Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273712/
https://www.ncbi.nlm.nih.gov/pubmed/25479151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273712/
https://www.ncbi.nlm.nih.gov/pubmed/25479151

Ejemplares similares